Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
Background: Anti-staphylococcal penicillins have long been the first-line treatment option for methicillin-susceptible Staphylococcus aureus (MSSA) infections. Recent retrospective data comparing nafcillin and cefazolin report similar clinical efficacy despite concerns about high inoculum MSSA infec...
Saved in:
Main Authors: | Marguerite L. Monogue (Author), Jessica K. Ortwine (Author), Wenjing Wei (Author), Khalid Eljaaly (Author), Kavita P. Bhavan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018) -
Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible <i>Staphylococcus aureus</i> in a Tertiary Care University Hospital
by: Atsushi Uda, et al.
Published: (2021) -
Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive <i>Staphylococcus aureus</i>: A Single-Center Retrospective Study
by: Jun Hirai, et al.
Published: (2022) -
Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
by: Davie Wong, et al.
Published: (2020) -
Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
by: Alexandra G. Mills, et al.
Published: (2023)